Bone Regeneration, Osteoporosis and Osteoarthritis

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Orthopedics".

Deadline for manuscript submissions: 15 July 2025 | Viewed by 902

Special Issue Editor


E-Mail Website
Guest Editor
Department of Woman and Child Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Interests: bone loss; metabolic disease; osteoporosis; menopause

Special Issue Information

Dear Colleagues,

Worldwide, the increasing attention paid to the issue of ‘osteoporosis’ stems primarily from the growing elderly population who find themselves at greater risk of fractures.

Although there is mounting evidence of the detrimental impact of this skeletal disease on individual as well as on public and social health, and several pharmacological and non-pharmacological strategies could clearly be helpful in terms of primary and secondary fracture prevention, an appropriate culture surrounding bone metabolism still seems necessary.

The aim of this Special Issue is to build an updated overview of the most intriguing and innovative aspects of bone metabolism and anti-osteoporotic therapies.

We invite therefore colleagues from around the world to report their clinical experience with case series and/or reviews about bone loss.

With kind regards,

Dr. Anna Capozzi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bone loss
  • osteoporosis
  • bone mineral density
  • fracture
  • bone quality
  • trabecular bone score

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 2154 KiB  
Review
Bone Health for Gynaecologists
by Angel Yordanov, Mariela Vasileva-Slaveva, Eva Tsoneva, Stoyan Kostov and Vesselina Yanachkova
Medicina 2025, 61(3), 530; https://doi.org/10.3390/medicina61030530 - 18 Mar 2025
Viewed by 710
Abstract
Osteoporosis, the most common bone disorder, profoundly impacts women’s health, especially during postmenopausal phases. Characterised by diminished bone mineral density (BMD), it increases the risk of fractures, affecting mobility, quality of life, and potentially mortality. The present review analyses the intricate interactions among [...] Read more.
Osteoporosis, the most common bone disorder, profoundly impacts women’s health, especially during postmenopausal phases. Characterised by diminished bone mineral density (BMD), it increases the risk of fractures, affecting mobility, quality of life, and potentially mortality. The present review analyses the intricate interactions among physiological alterations, diseases, and medications that lead to bone mineral density reduction in women. It underscores the importance of gynaecologists in the prevention, diagnosis, and management of osteoporosis via early risk assessment, suitable hormone treatment, and lifestyle modifications. Essential considerations encompass the categorisation of osteoporosis into primary (age-related) and secondary (attributable to diseases or pharmacological treatments) types, with particular emphasis on predisposing conditions such as premature menopause, hormone deficits, and cancer therapies. The significance of diagnostic instruments such as DXA and novel methodologies like trabecular bone score and quantitative ultrasonography is emphasised for precise evaluation and surveillance. The review also addresses nutritional methods, physical exercise, and pharmaceutical interventions, including hormone replacement therapy (HRT), selective oestrogen receptor modulators (SERMs), and other anti-resorptive drugs, to preserve bone health. This review highlights the important role of gynaecologists in maintaining women’s bone health, promoting a proactive strategy to avert osteoporosis-related complications and enhance long-term results. Full article
(This article belongs to the Special Issue Bone Regeneration, Osteoporosis and Osteoarthritis)
Show Figures

Figure 1

Back to TopTop